Delivery Order SPE2DB22D1106-SPE2DB24FDYW9
- Not listed
- This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,774.71 and an ultimate completion date of February 21, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Advair HFA 230-21 MCG Inhaler, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 11, 2024, and a ceiling value of $4,526.43. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of Advair HFA 45-21 MCG inhalers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 7, 2024, with a completion date of February 8, 2024. The contract has a ceiling value of $1,335.71 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,030.91 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 16, 2024. The contract is not designated under any set-aside program. It is issued under Amerisourcebergen's existing Indefinite...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,603.30, and has an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,077.32 and is a delivery order with a firm fixed-price pricing type. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. The contract has a total ceiling value of $4,877.12 and is a firm fixed-price delivery order, with an ultimate completion date of June 4, 2024. The contract was awarded on June 3, 2024, and there...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers, with a ceiling value of $7,052.30. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,671.68 and is a firm fixed price delivery order. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation. The ultimate completion date is August 28, 2024. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award is for the delivery of 4,565,505 units of the Advair HFA 230-21 MCG Inhaler (12gm) to the Defense Logistics Agency (DLA) Troop Support Medical. The $17,171.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 19, 2024 with a final completion date of August 20, 2024. The contract is not designated as a set-aside. This delivery order falls under Amerisourcebergen's Indefinite Delivery Contract (IDC)...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDYW9Delivery Order
This federal contract award is for the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 6, 2024, with a completion date of February 7, 2024. The ceiling value of the contract is $5,634.20, and it is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 2/6/24 |